Featured Research

from universities, journals, and other organizations

Inhibiting Cell-Death Gene May Slow ALS Progression

Date:
July 2, 1997
Source:
Massachusetts General Hospital
Summary:
Researchers from the Massachusetts General Hospital have found that a cell-death gene may play a role in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). In the July 3Nature, they report that inhibiting the ICE cell-death gene slowed the progression of an ALS-like illness in mice.

A team of researchers from the Massachusetts General Hospital (MGH) has found evidence that a key programmed cell death gene may play a role in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). In the July 3 issue of Nature, the team reports that inhibiting the activity of the gene coding for a protein called ICE -- the first identified mammalian cell-death gene -- slowed the progression of symptoms in mice with a gene mutation causing an ALS-like illness.

Related Articles


ALS is a degenerative disorder of the brain and spinal cord, which causes weakness and wasting of muscles. Patients eventually become paralyzed and die, usually within five years. The gene that causes ALS when mutated was discovered in 1993 by researchers in MGH laboratory of Robert H. Brown Jr., MD, PhD, who is a coauthor of the current Nature paper. That gene codes for production of an enzyme called superoxide dismutase (SOD1), known to neutralize dangerous chemicals called free radicals in the body.

In the current study, the MGH researchers used two strains of transgenic mice with mutations in key genes. One strain with mutations in SOD1 develops an ALS-like muscle disease. The other strain has a specific mutation called M17Z in the gene coding for the ICE protein. Discovered in 1993 by a team of researchers from the MGH and the Massachusetts Institute of Technology, the ICE gene controls some instances of programmed cell death, a natural process in which cells not necessary for normal development essentially commit suicide. The leader of the group identifying the ICE gene was Junying Yuan, PhD, also a coauthor of the Nature paper.

The researchers crossed a group of SOD1 mutant mice with a group of M17Z/ICE mutant mice and determined which of their offspring carried mutations in both genes. While mice with both mutations developed ALS-like symptoms at about the same age as those mice with the SOD1 mutation only -- about 240 days old -- the mice with both mutations lived significantly longer after disease onset than those with the single mutation -- 27 days versus almost 12 days. The results suggest that inhibiting activity of the ICE gene could slow the progression of ALS in human patients.

"This result is the first indication of the genetic pathway which mediates cell death in ALS," says Robert M. Friedlander, MD, a resident in the MGH Neurosurgical Service, who is first author of the report. "This novel insight into cell death in ALS opens a new avenue of possible therapy using drugs that inhibit the ICE cell death gene family."

Yuan, who was a member of the MGH Cardiovascular Research Center (CVRC) when this research was began, now is in the Cell Biology Department at Harvard Medical School.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts General Hospital. "Inhibiting Cell-Death Gene May Slow ALS Progression." ScienceDaily. ScienceDaily, 2 July 1997. <www.sciencedaily.com/releases/1997/07/970702155045.htm>.
Massachusetts General Hospital. (1997, July 2). Inhibiting Cell-Death Gene May Slow ALS Progression. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/1997/07/970702155045.htm
Massachusetts General Hospital. "Inhibiting Cell-Death Gene May Slow ALS Progression." ScienceDaily. www.sciencedaily.com/releases/1997/07/970702155045.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins